Nomura Growth and Income Fund
Delaware Group Equity Funds IV · 3 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Nomura Growth and Income Fund is an actively managed U.S. equity fund. 7% of FGIPX’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 94% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2026 Q1
Nomura Growth and Income Fund seeks long-term growth of capital and current income.
The fund invests primarily in common stocks of large-size companies selected for above-average dividend yields combined with demonstrated business quality, including superior profitability, balance sheet strength, earnings stability, and reasonable valuations relative to growth prospects and peers. The fund may also hold convertible securities, REITs, and other income-generating equity securities. Day-to-day management is delegated to Macquarie Investment Management Global Limited, which applies a systematic bottom-up approach to identify companies positioned for sustainable growth that may result in price appreciation alongside current income.
| Share class | Expense ratio |
|---|---|
| FGIPX | 0.77% |
| FGINX | 1.02% |
| FGIQX | 0.69% |
Portfolio turnover 34.00% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 93.84% |
| Cash & short-term | 6.11% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Financials | 19.6% |
| Health Care | 17.0% |
| Information Technology | 14.0% |
| Energy | 9.7% |
| 7 smaller | 39.7% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +40.27% | +88.77% | +108.25% | 10.76% | -6.49% | |
| +39.94% | +87.36% | +105.76% | 10.79% | -6.49% | |
| +40.30% | +89.18% | +109.06% | 10.77% | -6.52% |
These classes hold the same portfolio, so the 3.30pp spread over 5 years is the cost difference between them — roughly 0.66pp a year — not a difference in what they own.
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| CSCO | CISCO SYSTEMS INCCSCO | 4.88% | $117.46 | $115.42M | 982.6K |
| C | CITIGROUP INCC | 3.80% | $139.96 | $90.01M | 643.1K |
| CVS | CVS HEALTH CORPCVS | 3.55% | $103.45 | $83.96M | 811.6K |
| XOM | EXXONMOBIL HOLDINGS CORPXOM | 3.54% | $136.72 | $83.93M | 613.8K |
| PM | PHILIP MORRIS INTERNATIONAL INCPM | 3.33% | $180.91 | $78.82M | 435.7K |
| GILD | GILEAD SCIENCES INCGILD | 3.17% | $126.34 | $75.15M | 594.8K |
| AAPL | APPLE INCAAPL | 3.15% | $289.36 | $74.51M | 257.5K |
| BMY | BRISTOL-MYERS SQUIBB COMPANYBMY | 2.98% | $57.62 | $70.62M | 1.2M |
| — | INVESCO LTD | 2.98% | $26.39 | $70.56M | 2.7M |
| BPOP | POPULAR INCBPOP | 2.80% | $164.18 | $66.21M | 403.3K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 34.18% of net assets, top 25 66.47%, across 66 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free